China Universal Asset Management Co., Ltd. Nektar Therapeutics Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$0.51 - $1.05 $1,223 - $2,518	2,399 Added 96.69%	4,880 $2,000
Q3 2023 Oct 30, 2023	BUY	$0.51 - $1.05 $1,223 - $2,518	2,399 Added 96.69%	4,880 $3,000
Q2 2023 May 21, 2024	SELL	$0.53 - $1.03 $43 - $85	-83 Reduced 3.24%	2,481 $1,000
Q2 2023 Jul 27, 2023	SELL	$0.53 - $1.03 $43 - $85	-83 Reduced 3.24%	2,481 $1,000
Q1 2023 May 21, 2024	BUY	$0.64 - $3.15 $418 - $2,060	654 Added 34.24%	2,564 $1,000
Q1 2023 Apr 27, 2023	BUY	$0.64 - $3.15 $418 - $2,060	654 Added 34.24%	2,564 $2,000
Q4 2022 May 21, 2024	BUY	$2.03 - $4.28 $3,877 - $8,174	1,910 New	1,910 $4,000
Q4 2022 Jan 31, 2023	BUY	$2.03 - $4.28 $314 - $663	155 Added 8.83%	1,910 $4,000
Q3 2022 Oct 21, 2022	BUY	$3.04 - $5.14 $5,335 - $9,020	1,755 New	1,755 $6,000

Others Institutions Holding NKTR

# of Institutions

147

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$17 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$16.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$14 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$10.1 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$9.84 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $201M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account